CEL-SCI Corp (AMEX:CVM)

CAPS Rating: 2 out of 5

The Company engages in the research and development of drugs and vaccines. Its most advanced product, Multikine, manufactured using the Company's proprietary cell culture technologies, is being developed for the treatment of cancer.

Featured Broker Partners


Advertisement